• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰语翻译及 SARC-F 工具用于肌少症评估的验证。

Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia.

机构信息

Department of Geriatric Medicine and Gerontology, Poznan University of Medical Sciences, Poznań, Poland.

出版信息

Clin Interv Aging. 2020 Apr 22;15:567-574. doi: 10.2147/CIA.S245074. eCollection 2020.

DOI:10.2147/CIA.S245074
PMID:32368023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7185989/
Abstract

INTRODUCTION

Completion of the SARC-F questionnaire constitutes the obligatory first step in the diagnostic process of sarcopenia, according to the revised European consensus on the definition and diagnosis of sarcopenia published by the European Working Group on Sarcopenia in Older People2 (EWGSOP2). SARC-F has been recognized as the most up-to-date and coherent screening tool for sarcopenia. The aim of the study was to translate and to validate the Polish version of the SARC-F questionnaire.

MATERIALS AND METHODS

The validation process was performed in two stages: 1) translation and intercultural adaptation and 2) clinical validation. The inclusion criteria were as follows: age ≥65 years, unimpaired mobility, and no cognitive impairment. The EWGSOP2 criteria were used to diagnose sarcopenia. Hand grip strength measurement, physical fitness test, and body weight composition analysis were conducted. Sensitivity, specificity, accuracy-likelihood ratios, and SARC-F predictive values were calculated using the EWGSOP2 criteria.

RESULTS

Sixty-seven people participated in the study of whom 21% were diagnosed with sarcopenia (SARC-F score: ≥4). The reliability of the questionnaire based on the Cronbach's alpha coefficient was 0.784. Sensitivity, specificity, and negative predictive values were 92.9%, 98.1%, and 98.1%, respectively.

CONCLUSION

The process of validating the SARC-F questionnaire against Polish conditions demonstrated its applicability as a simple and reliable tool for diagnosing sarcopenia in daily clinical practice with older adults.

摘要

简介

根据欧洲老年人肌肉减少症工作组(EWGSOP2)发布的修订版欧洲肌少症定义和诊断共识,完成 SARC-F 问卷构成肌少症诊断过程的必要第一步。SARC-F 已被认为是最新和最连贯的肌少症筛查工具。本研究的目的是翻译和验证 SARC-F 问卷的波兰语版本。

材料和方法

验证过程分两个阶段进行:1)翻译和跨文化适应,2)临床验证。纳入标准为:年龄≥65 岁,活动能力不受影响,无认知障碍。使用 EWGSOP2 标准诊断肌少症。进行握力测量、体能测试和体重成分分析。使用 EWGSOP2 标准计算灵敏度、特异性、准确性似然比和 SARC-F 预测值。

结果

共有 67 人参加了这项研究,其中 21%被诊断为肌少症(SARC-F 评分:≥4)。基于 Cronbach's alpha 系数的问卷可靠性为 0.784。灵敏度、特异性和阴性预测值分别为 92.9%、98.1%和 98.1%。

结论

针对波兰情况验证 SARC-F 问卷的过程表明,它可以作为一种简单可靠的工具,用于在日常临床实践中诊断老年人的肌少症。

相似文献

1
Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia.波兰语翻译及 SARC-F 工具用于肌少症评估的验证。
Clin Interv Aging. 2020 Apr 22;15:567-574. doi: 10.2147/CIA.S245074. eCollection 2020.
2
Polish version of SARC-F to assess sarcopenia in older adults: An examination of reliability and validity.波兰版 SARC-F 用于评估老年人肌少症:信度和效度检验。
PLoS One. 2020 Dec 21;15(12):e0244001. doi: 10.1371/journal.pone.0244001. eCollection 2020.
3
Reliability and Validity of SARC-F Questionnaire to Assess Sarcopenia Among Vietnamese Geriatric Patients.SARC-F 问卷评估越南老年患者肌少症的可靠性和有效性。
Clin Interv Aging. 2020 Jun 9;15:879-886. doi: 10.2147/CIA.S254397. eCollection 2020.
4
Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People.评估老年人肌少症的 SARC-F 问卷西班牙语版的翻译与验证。
J Nutr Health Aging. 2019;23(6):518-524. doi: 10.1007/s12603-019-1204-z.
5
SARC-F as a case-finding tool for sarcopenia according to the EWGSOP2. National validation and comparison with other diagnostic standards.SARC-F 作为 EWGSOP2 推荐的肌少症筛查工具。全国验证及与其他诊断标准的比较。
Aging Clin Exp Res. 2021 Jul;33(7):1821-1829. doi: 10.1007/s40520-020-01782-y. Epub 2021 Jan 28.
6
Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures.SARC-F 在肌少症定义、肌肉质量和功能测量方面的表现。
J Nutr Health Aging. 2018;22(8):898-903. doi: 10.1007/s12603-018-1067-8.
7
German Version of SARC-F: Translation, Adaption, and Validation.SARC-F 的德译版:翻译、改编和验证。
J Am Med Dir Assoc. 2020 Jun;21(6):747-751.e1. doi: 10.1016/j.jamda.2019.12.011. Epub 2020 Jan 21.
8
Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study.《评估肌少症的 SARC-F 问卷韩国版的验证:韩国虚弱与衰老队列研究》。
J Am Med Dir Assoc. 2018 Jan;19(1):40-45.e1. doi: 10.1016/j.jamda.2017.07.006. Epub 2017 Aug 31.
9
[Evaluation of the Hungarian-language SARC-F sarcopenia-screening questionnaire].[匈牙利语SARC - F肌少症筛查问卷的评估]
Orv Hetil. 2020 Nov 22;161(47):2000-2005. doi: 10.1556/650.2020.31932.
10
Cross-cultural adaptation and validation of the Greek Version of the SARC-F for evaluating sarcopenia in Greek older adults.跨文化调适与验证希腊版 SARC-F 于评估希腊老年族群肌少症。
J Musculoskelet Neuronal Interact. 2020 Dec 1;20(4):505-512.

引用本文的文献

1
Arabic Adaptation and Validation of the SARC-F Questionnaire for Sarcopenia Screening in Elderly Populations: Exploration of Associated Factors.阿拉伯语版SARC-F问卷在老年人群肌肉减少症筛查中的改编与验证:相关因素探索
J Aging Res. 2025 Aug 8;2025:7405872. doi: 10.1155/jare/7405872. eCollection 2025.
2
Validity and reliability of the Persian version of the SARC-F questionnaire among Iranian older adults.SARC - F问卷波斯语版本在伊朗老年人中的效度和信度。
BMC Geriatr. 2025 Jul 28;25(1):551. doi: 10.1186/s12877-025-06214-y.
3
SARC-F: an effective screening tool for detecting sarcopenia and predicting health-related quality of life in older women in Sri Lanka.

本文引用的文献

1
Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group.用于评估肌肉减少症的SARC-F量表的跨文化调适与验证:来自欧盟老年医学学会肌肉减少症特别兴趣小组的方法学报告
Eur Geriatr Med. 2018 Feb;9(1):23-28. doi: 10.1007/s41999-017-0003-5. Epub 2017 Dec 21.
2
SARC-F: A validation study with community-dwelling older Japanese adults.SARC-F:一项针对社区居住的日本老年成年人的验证研究。
Geriatr Gerontol Int. 2019 Nov;19(11):1172-1178. doi: 10.1111/ggi.13768. Epub 2019 Sep 18.
3
Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People.
SARC-F:一种用于检测斯里兰卡老年女性肌肉减少症并预测其健康相关生活质量的有效筛查工具。
BMC Geriatr. 2025 Feb 25;25(1):129. doi: 10.1186/s12877-025-05786-z.
4
Agreement analysis and associated factors of SARC-F and SARC-CALF in screening of risk sarcopenia in people living with human immunodeficiency virus.SARC-F和SARC-CALF在筛查人类免疫缺陷病毒感染者肌肉减少症风险中的一致性分析及相关因素
Clinics (Sao Paulo). 2025 Jan 2;80:100565. doi: 10.1016/j.clinsp.2024.100565. eCollection 2025.
5
Insights into geriatric health: primary sarcopenia and innate immunity dynamics, examining SARC-F, serum TLR 4, TLR 9, and resolvin levels.老年健康洞察:原发性肌肉减少症和固有免疫动态,研究 SARC-F、血清 TLR4、TLR9 和解析素水平。
Intern Emerg Med. 2024 Oct;19(7):1867-1875. doi: 10.1007/s11739-024-03678-5. Epub 2024 Jun 23.
6
Comparison of six screening methods for sarcopenia among rural community-dwelling older adults: a diagnostic accuracy study.农村社区老年人肌少症 6 种筛查方法的比较:一项诊断准确性研究。
Eur Geriatr Med. 2024 Jun;15(3):681-688. doi: 10.1007/s41999-024-00955-6. Epub 2024 Mar 7.
7
Symptoms of Sarcopenia and Physical Fitness through the Senior Fitness Test.肌少症和身体机能通过老年人健康测试的表现。
Int J Environ Res Public Health. 2023 Feb 3;20(3):2711. doi: 10.3390/ijerph20032711.
8
Can Biological Drugs Diminish the Risk of Sarcopenia in Psoriatic Patients? A Systematic Review.生物药物能否降低银屑病患者肌肉减少症的风险?一项系统评价。
Life (Basel). 2022 Mar 16;12(3):435. doi: 10.3390/life12030435.
9
Sarcopenia Identification during Comprehensive Geriatric Assessment.肌少症的综合老年评估识别。
Int J Environ Res Public Health. 2021 Dec 21;19(1):32. doi: 10.3390/ijerph19010032.
10
SARC-F as a case-finding tool for sarcopenia according to the EWGSOP2. National validation and comparison with other diagnostic standards.SARC-F 作为 EWGSOP2 推荐的肌少症筛查工具。全国验证及与其他诊断标准的比较。
Aging Clin Exp Res. 2021 Jul;33(7):1821-1829. doi: 10.1007/s40520-020-01782-y. Epub 2021 Jan 28.
评估老年人肌少症的 SARC-F 问卷西班牙语版的翻译与验证。
J Nutr Health Aging. 2019;23(6):518-524. doi: 10.1007/s12603-019-1204-z.
4
Sarcopenia: revised European consensus on definition and diagnosis.肌少症:定义和诊断的欧洲共识修订版。
Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.
5
Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.国际衰弱与肌少症研究特别工作组关于ICD - 10对肌少症临床实践及临床试验影响的报告
J Frailty Aging. 2018;7(1):2-9. doi: 10.14283/jfa.2017.30.
6
Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study.《评估肌少症的 SARC-F 问卷韩国版的验证:韩国虚弱与衰老队列研究》。
J Am Med Dir Assoc. 2018 Jan;19(1):40-45.e1. doi: 10.1016/j.jamda.2017.07.006. Epub 2017 Aug 31.
7
Developing and Validating an Age-Independent Equation Using Multi-Frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and Establishing a Cutoff for Sarcopenia.利用多频生物电阻抗分析开发并验证一个与年龄无关的方程,用于估计四肢骨骼肌质量并确定肌肉减少症的临界值。
Int J Environ Res Public Health. 2017 Jul 19;14(7):809. doi: 10.3390/ijerph14070809.
8
Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults.用于评估墨西哥社区居住老年人肌肉减少症的SARC-F西班牙语版本的跨文化适应与验证
J Am Med Dir Assoc. 2016 Dec 1;17(12):1142-1146. doi: 10.1016/j.jamda.2016.09.008. Epub 2016 Nov 1.
9
Sarcopenia in daily practice: assessment and management.日常实践中的肌肉减少症:评估与管理。
BMC Geriatr. 2016 Oct 5;16(1):170. doi: 10.1186/s12877-016-0349-4.
10
Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice.增强SARC-F:改善临床实践中的肌肉减少症筛查
J Am Med Dir Assoc. 2016 Dec 1;17(12):1136-1141. doi: 10.1016/j.jamda.2016.08.004. Epub 2016 Sep 17.